Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 552

1.

TGF-β2 silencing to target biliary-derived liver diseases.

Dropmann A, Dooley S, Dewidar B, Hammad S, Dediulia T, Werle J, Hartwig V, Ghafoory S, Woelfl S, Korhonen H, Janicot M, Wosikowski K, Itzel T, Teufel A, Schuppan D, Stojanovic A, Cerwenka A, Nittka S, Piiper A, Gaiser T, Beraza N, Milkiewicz M, Milkiewicz P, Brain JG, Jones DEJ, Weiss TS, Zanger UM, Ebert M, Meindl-Beinker NM.

Gut. 2020 Jan 28. pii: gutjnl-2019-319091. doi: 10.1136/gutjnl-2019-319091. [Epub ahead of print]

2.

Rapid Communication: Development of a subcutaneous ear implant to deliver an anaplasmosis vaccine to dairy steers.

Curtis AK, Reif KE, Kleinhenz MD, Martin MS, Skinner B, Kelly SM, Jones DE, Reppert EJ, Montgomery SR, Narasimhan B, Anantatat T, Jaberi-Douraki M, Coetzee JF.

J Anim Sci. 2019 Dec 31. pii: skz392. doi: 10.1093/jas/skz392. [Epub ahead of print]

PMID:
31889177
3.

The toxicity of the methylimidazolium ionic liquids, with a focus on M8OI and hepatic effects.

Leitch AC, Abdelghany TM, Probert PM, Dunn MP, Meyer SK, Palmer JM, Cooke MP, Blake LI, Morse K, Rosenmai AK, Oskarsson A, Bates L, Figueiredo RS, Ibrahim I, Wilson C, Abdelkader NF, Jones DE, Blain PG, Wright MC.

Food Chem Toxicol. 2020 Feb;136:111069. doi: 10.1016/j.fct.2019.111069. Epub 2019 Dec 27.

4.

HEP-19-1549 Pembrolizumab as a cause of cholangiopathy in a patient with metastatic melanoma.

Stuart L, Lambourne B, Turner P, Jones DE, Plummer R, Cresti N, Dyson JK.

Hepatology. 2019 Dec 23. doi: 10.1002/hep.31089. [Epub ahead of print]

PMID:
31872447
5.

Important issues in estimating costs of early childhood educational interventions: An example from the REDI Program.

Jones DE, Bierman KL, Crowley DM, Welsh JA, Gest J.

Child Youth Serv Rev. 2019 Dec;107. pii: 104498. doi: 10.1016/j.childyouth.2019.104498. Epub 2019 Sep 11.

PMID:
31866702
6.

Letter: histology is relevant for risk stratification in primary biliary cholangitis.

Carbone M, D'Amato D, Hirschfield GM, Jones DEJ, Mells GF.

Aliment Pharmacol Ther. 2020 Jan;51(1):192-193. doi: 10.1111/apt.15583. No abstract available.

PMID:
31850571
7.

Selective small molecule PARG inhibitor causes replication fork stalling and cancer cell death.

Houl JH, Ye Z, Brosey CA, Balapiti-Modarage LPF, Namjoshi S, Bacolla A, Laverty D, Walker BL, Pourfarjam Y, Warden LS, Babu Chinnam N, Moiani D, Stegeman RA, Chen MK, Hung MC, Nagel ZD, Ellenberger T, Kim IK, Jones DE, Ahmed Z, Tainer JA.

Nat Commun. 2019 Dec 11;10(1):5654. doi: 10.1038/s41467-019-13508-4.

8.

3-Methylglutaric acid in energy metabolism.

Jones DE, Perez L, Ryan RO.

Clin Chim Acta. 2020 Mar;502:233-239. doi: 10.1016/j.cca.2019.11.006. Epub 2019 Nov 12. Review.

PMID:
31730811
9.

Unique Molecular Features in High-Risk Histology Endometrial Cancers.

Pandita P, Wang X, Jones DE, Collins K, Hawkins SM.

Cancers (Basel). 2019 Oct 27;11(11). pii: E1665. doi: 10.3390/cancers11111665. Review.

10.

Sustained antigen release polyanhydride-based vaccine platform for immunization against bovine brucellosis.

Boggiatto PM, Schaut RG, Kanipe C, Kelly SM, Narasimhan B, Jones DE, Olsen SC.

Heliyon. 2019 Aug 29;5(8):e02370. doi: 10.1016/j.heliyon.2019.e02370. eCollection 2019 Aug.

11.

Chapter II: New Fathers' and Mothers' Daily Stressors and Resources Influence Parent Adjustment and Family Relationships.

Feinberg ME, Jones DE, McDaniel BT, Liu S, Almeida D.

Monogr Soc Res Child Dev. 2019 Mar;84(1):18-34. Epub 2019 Apr 29.

12.

Prospective, dyadic links between posttraumatic stress disorder symptoms and family violence in the early years of parenthood.

Marshall AD, Le Y, Fredman SJ, Feinberg ME, Taverna EC, Jones DE.

J Fam Psychol. 2019 Dec;33(8):1000-1006. doi: 10.1037/fam0000557. Epub 2019 Jul 18.

PMID:
31318268
13.

Position statement on access to care in rare liver diseases: advancements of the European reference network (ERN) RARE-LIVER.

Bernts LHP, Jones DEJ, Kaatee MM, Lohse AW, Schramm C, Sturm E, Drenth JPH.

Orphanet J Rare Dis. 2019 Jul 8;14(1):169. doi: 10.1186/s13023-019-1152-z.

14.

British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis.

Chapman MH, Thorburn D, Hirschfield GM, Webster GGJ, Rushbrook SM, Alexander G, Collier J, Dyson JK, Jones DE, Patanwala I, Thain C, Walmsley M, Pereira SP.

Gut. 2019 Aug;68(8):1356-1378. doi: 10.1136/gutjnl-2018-317993. Epub 2019 Jun 1.

15.

Prospective Relations Between Prenatal Maternal Cortisol and Child Health Outcomes.

Roettger ME, Schreier HMC, Feinberg ME, Jones DE.

Psychosom Med. 2019 Jul/Aug;81(6):557-565. doi: 10.1097/PSY.0000000000000705.

PMID:
31058707
16.

Advancing Research and Measurement on Fathering and Child Development.

Volling BL, Cabrera NJ, Feinberg ME, Jones DE, McDaniel BT, Liu S, Almeida D, Lee JK, Schoppe-Sullivan SJ, Feng X, Gerhardt ML, Dush CMK, Stevenson MM, Safyer P, Gonzalez R, Lee JY, Piskernik B, Ahnert L, Karberg E, Malin J, Kuhns C, Fagan J, Kaufman R, Dyer WJ, Parke RD, Cookston JT.

Monogr Soc Res Child Dev. 2019 Mar;84(1):7-160. doi: 10.1111/mono.12404.

PMID:
31034620
17.

Pruritus secondary to primary biliary cholangitis: a review of the pathophysiology and management with phototherapy.

Hussain AB, Samuel R, Hegade VS, Jones DE, Reynolds NJ.

Br J Dermatol. 2019 Dec;181(6):1138-1145. doi: 10.1111/bjd.17933. Epub 2019 Jul 28. Review.

PMID:
30920648
18.
19.

Cardiovascular and growth outcomes of C57Bl/6J mice offspring exposed to maternal stress and ionizing radiation during pregnancy.

Sreetharan S, Stoa L, Cybulski ME, Jones DE, Lee AH, Kulesza AV, Tharmalingam S, Boreham DR, Tai TC, Wilson JY.

Int J Radiat Biol. 2019 Aug;95(8):1085-1093. doi: 10.1080/09553002.2019.1589025. Epub 2019 Apr 16.

PMID:
30831046
20.

PBC: Better Solutions to Beat Feeling Beat.

Phaw NA, Jones DEJ.

Dig Dis Sci. 2019 Aug;64(8):2075-2077. doi: 10.1007/s10620-019-05552-3. No abstract available.

PMID:
30830519
21.

Autotaxin, bile acid profile and effect of ileal bile acid transporter inhibition in primary biliary cholangitis patients with pruritus.

Hegade VS, Pechlivanis A, McDonald JAK, Rees D, Corrigan M, Hirschfield GM, Taylor-Robinson SD, Holmes E, Marchesi JR, Kendrick S, Jones DE.

Liver Int. 2019 May;39(5):967-975. doi: 10.1111/liv.14069. Epub 2019 Feb 25.

PMID:
30735608
22.

Tsuji-Trost Cyclization of Disulfonamides: Synthesis of 12-Membered, 11-Membered, and Pyridine-Fused Macrocyclic Triamines.

Ali R, Anugu S, Chawla R, Demillo VG, Goulinet-Mateo F, Gyawali S, Hamal S, Jones DE, Lamprecht K, Le T, Lumangtad LA, Pflug NC, Sama A, Scarbrough ED, Bell TW.

ACS Omega. 2019 Jan 31;4(1):1254-1264. doi: 10.1021/acsomega.8b02555. Epub 2019 Jan 15.

23.

Evaluation of a Novel Preference Assessment Tool for Patients with Multiple Sclerosis.

Col NF, Solomon AJ, Springmann V, Ionete C, Alvarez E, Tierman B, Kutz C, Morales IB, Griffin C, Ngo LH, Jones DE, Phillips G, Hopson A, Pbert L.

Int J MS Care. 2018 Nov-Dec;20(6):260-267. doi: 10.7224/1537-2073.2017-021.

24.

Pruritus Is Common and Undertreated in Patients With Primary Biliary Cholangitis in the United Kingdom.

Hegade VS, Mells GF, Fisher H, Kendrick S, DiBello J, Gilchrist K, Alexander GJ, Hirschfield GM, Sandford RN, Jones DEJ; UK-PBC Consortium.

Clin Gastroenterol Hepatol. 2019 Jun;17(7):1379-1387.e3. doi: 10.1016/j.cgh.2018.12.007. Epub 2018 Dec 14.

PMID:
30557739
25.

Use of praziquantel to control platyhelminth parasites of fish.

Bader C, Starling DE, Jones DE, Brewer MT.

J Vet Pharmacol Ther. 2019 Mar;42(2):139-153. doi: 10.1111/jvp.12735. Epub 2018 Dec 16. Review.

PMID:
30556228
26.

Amino acid residues in five separate HLA genes can explain most of the known associations between the MHC and primary biliary cholangitis.

Darlay R, Ayers KL, Mells GF, Hall LS, Liu JZ, Almarri MA, Alexander GJ, Jones DE, Sandford RN, Anderson CA, Cordell HJ.

PLoS Genet. 2018 Dec 3;14(12):e1007833. doi: 10.1371/journal.pgen.1007833. eCollection 2018 Dec.

27.

CYP3C gene regulation by the aryl hydrocarbon and estrogen receptors in zebrafish.

Shaya L, Jones DE, Wilson JY.

Toxicol Appl Pharmacol. 2019 Jan 1;362:77-85. doi: 10.1016/j.taap.2018.10.021. Epub 2018 Oct 25.

PMID:
30393146
28.

Symptoms of PBC - Pathophysiology and management.

Khanna A, Leighton J, Lee Wong L, Jones DE.

Best Pract Res Clin Gastroenterol. 2018 Jun - Aug;34-35:41-47. doi: 10.1016/j.bpg.2018.06.007. Epub 2018 Jun 14. Review.

PMID:
30343709
29.

Inequity of care provision and outcome disparity in autoimmune hepatitis in the United Kingdom.

Dyson JK, Wong LL, Bigirumurame T, Hirschfield GM, Kendrick S, Oo YH, Lohse AW, Heneghan MA, Jones DEJ; UK-AIH Consortium.

Aliment Pharmacol Ther. 2018 Nov;48(9):951-960. doi: 10.1111/apt.14968. Epub 2018 Sep 18.

30.

Bezafibrate in Primary Biliary Cholangitis.

Jones DE, Hegade VS.

N Engl J Med. 2018 Sep 6;379(10):984. doi: 10.1056/NEJMc1809061. No abstract available.

PMID:
30207645
31.

Increased sensitivity of Treg cells from patients with PBC to low dose IL-12 drives their differentiation into IFN-γ secreting cells.

Liaskou E, Patel SR, Webb G, Bagkou Dimakou D, Akiror S, Krishna M, Mells G, Jones DE, Bowman SJ, Barone F, Fisher BA, Hirschfield GM.

J Autoimmun. 2018 Nov;94:143-155. doi: 10.1016/j.jaut.2018.07.020. Epub 2018 Aug 14.

PMID:
30119881
32.

Identification of Primary Congenital Hypothyroidism Based on Two Newborn Screens - Utah, 2010-2016.

Jones DE, Hart K, Shapira SK, Murray M, Atkinson-Dunn R, Rohrwasser A.

MMWR Morb Mortal Wkly Rep. 2018 Jul 20;67(28):782-785. doi: 10.15585/mmwr.mm6728a4.

33.

Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score.

Carbone M, Nardi A, Flack S, Carpino G, Varvaropoulou N, Gavrila C, Spicer A, Badrock J, Bernuzzi F, Cardinale V, Ainsworth HF, Heneghan MA, Thorburn D, Bathgate A, Jones R, Neuberger JM, Battezzati PM, Zuin M, Taylor-Robinson S, Donato MF, Kirby J, Mitchell-Thain R, Floreani A, Sampaziotis F, Muratori L, Alvaro D, Marzioni M, Miele L, Marra F, Giannini E, Gaudio E, Ronca V, Bonato G, Cristoferi L, Malinverno F, Gerussi A, Stocken DD, Cordell HJ, Hirschfield GM, Alexander GJ, Sandford RN, Jones DE, Invernizzi P, Mells GF; Italian PBC Study Group and the UK–PBC Consortium.

Lancet Gastroenterol Hepatol. 2018 Sep;3(9):626-634. doi: 10.1016/S2468-1253(18)30163-8. Epub 2018 Jul 13.

34.

Identification of a xenobiotic as a potential environmental trigger in primary biliary cholangitis.

Probert PM, Leitch AC, Dunn MP, Meyer SK, Palmer JM, Abdelghany TM, Lakey AF, Cooke MP, Talbot H, Wills C, McFarlane W, Blake LI, Rosenmai AK, Oskarsson A, Figueiredo R, Wilson C, Kass GE, Jones DE, Blain PG, Wright MC.

J Hepatol. 2018 Nov;69(5):1123-1135. doi: 10.1016/j.jhep.2018.06.027. Epub 2018 Jul 11.

35.

Fatigue in chronic liver disease: New insights and therapeutic approaches.

Swain MG, Jones DEJ.

Liver Int. 2019 Jan;39(1):6-19. doi: 10.1111/liv.13919. Epub 2018 Aug 10. Review.

PMID:
29935104
36.

Clinical application of the GLOBE and United Kingdom-primary biliary cholangitis risk scores in a trial cohort of patients with primary biliary cholangitis.

Carbone M, Harms MH, Lammers WJ, Marmon T, Pencek R, MacConell L, Shapiro D, Jones DE, Mells GF, Hansen BE.

Hepatol Commun. 2018 Apr 19;2(6):683-692. doi: 10.1002/hep4.1180. eCollection 2018 Jun.

37.

Rituximab Is Ineffective for Treatment of Fatigue in Primary Biliary Cholangitis: A Phase 2 Randomized Controlled Trial.

Khanna A, Jopson L, Howel D, Bryant A, Blamire A, Newton JL, Jones DE.

Hepatology. 2019 Nov;70(5):1646-1657. doi: 10.1002/hep.30099. Epub 2018 Sep 22. Erratum in: Hepatology. 2020 Jan;71(1):404.

PMID:
29790196
38.

NI-0801, an anti-chemokine (C-X-C motif) ligand 10 antibody, in patients with primary biliary cholangitis and an incomplete response to ursodeoxycholic acid.

de Graaf KL, Lapeyre G, Guilhot F, Ferlin W, Curbishley SM, Carbone M, Richardson P, Moreea S, McCune CA, Ryder SD, Chapman RW, Floreani A, Jones DE, de Min C, Adams DH, Invernizzi P.

Hepatol Commun. 2018 Mar 23;2(5):492-503. doi: 10.1002/hep4.1170. eCollection 2018 May.

39.

Rituximab for the treatment of fatigue in primary biliary cholangitis (formerly primary biliary cirrhosis): a randomised controlled trial.

Khanna A, Jopson L, Howel D, Bryant A, Blamire A, Newton JL, Wilkinson J, Steel AJ, Bainbridge J, Stefanetti R, Cassidy S, Houghton D, Jones DE.

Southampton (UK): NIHR Journals Library; 2018 Apr.

40.

Trauma exposure and aggression toward partners and children: Contextual influences of fear and anger.

Marshall AD, Roettger ME, Mattern AC, Feinberg ME, Jones DE.

J Fam Psychol. 2018 Sep;32(6):710-721. doi: 10.1037/fam0000405. Epub 2018 May 7.

41.

Comprehensive systematic review summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Rae-Grant A, Day GS, Marrie RA, Rabinstein A, Cree BAC, Gronseth GS, Haboubi M, Halper J, Hosey JP, Jones DE, Lisak R, Pelletier D, Potrebic S, Sitcov C, Sommers R, Stachowiak J, Getchius TSD, Merillat SA, Pringsheim T.

Neurology. 2018 Apr 24;90(17):789-800. doi: 10.1212/WNL.0000000000005345. Review. Erratum in: Neurology. 2019 Oct 22;93(17):769.

PMID:
29686117
42.

Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Rae-Grant A, Day GS, Marrie RA, Rabinstein A, Cree BAC, Gronseth GS, Haboubi M, Halper J, Hosey JP, Jones DE, Lisak R, Pelletier D, Potrebic S, Sitcov C, Sommers R, Stachowiak J, Getchius TSD, Merillat SA, Pringsheim T.

Neurology. 2018 Apr 24;90(17):777-788. doi: 10.1212/WNL.0000000000005347. Erratum in: Neurology. 2019 Jan 8;92(2):112.

PMID:
29686116
43.

The Impact of Autoimmune Hepatitis and Its Treatment on Health Utility.

Wong LL, Fisher HF, Stocken DD, Rice S, Khanna A, Heneghan MA, Oo YH, Mells G, Kendrick S, Dyson JK, Jones DEJ; UK-AIH Consortium.

Hepatology. 2018 Oct;68(4):1487-1497. doi: 10.1002/hep.30031.

44.

The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines.

Hirschfield GM, Dyson JK, Alexander GJM, Chapman MH, Collier J, Hübscher S, Patanwala I, Pereira SP, Thain C, Thorburn D, Tiniakos D, Walmsley M, Webster G, Jones DEJ.

Gut. 2018 Sep;67(9):1568-1594. doi: 10.1136/gutjnl-2017-315259. Epub 2018 Mar 28.

45.

Preventing sensationalistic science and fake news about substance use.

Arndt S, Jones S.

Subst Abuse Treat Prev Policy. 2018 Mar 12;13(1):11. doi: 10.1186/s13011-018-0148-3. No abstract available.

46.

Primary sclerosing cholangitis.

Dyson JK, Beuers U, Jones DEJ, Lohse AW, Hudson M.

Lancet. 2018 Jun 23;391(10139):2547-2559. doi: 10.1016/S0140-6736(18)30300-3. Epub 2018 Feb 13. Review.

PMID:
29452711
47.

Standards of Evidence for Conducting and Reporting Economic Evaluations in Prevention Science.

Crowley DM, Dodge KA, Barnett WS, Corso P, Duffy S, Graham P, Greenberg M, Haskins R, Hill L, Jones DE, Karoly LA, Kuklinski MR, Plotnick R.

Prev Sci. 2018 Apr;19(3):366-390. doi: 10.1007/s11121-017-0858-1.

48.

A polyanhydride-based implantable single dose vaccine platform for long-term immunity.

Schaut RG, Brewer MT, Mendoza K, Jackman J, Narasimhan B, Jones DE.

Vaccine. 2018 Feb 8;36(7):1024-1025. doi: 10.1016/j.vaccine.2017.11.067. No abstract available.

PMID:
29413093
49.

A single dose polyanhydride-based vaccine platform promotes and maintains anti-GnRH antibody titers.

Schaut RG, Brewer MT, Hostetter JM, Mendoza K, Vela-Ramirez JE, Kelly SM, Jackman JK, Dell'Anna G, Howard JM, Narasimhan B, Zhou W, Jones DE.

Vaccine. 2018 Feb 8;36(7):1016-1023. doi: 10.1016/j.vaccine.2017.12.050.

PMID:
29413092
50.

Longitudinal links between work experiences and marital satisfaction in african american dual-earner couples.

Sun X, McHale SM, Crouter AC, Jones DE.

J Fam Psychol. 2017 Dec;31(8):1029-1039. doi: 10.1037/fam0000381.

Supplemental Content

Loading ...
Support Center